Fungal Dx 26

December 2-4, 2026 Bethesda, MD, USA & Online

A Hybrid Event

Early Abstract Submission Now Open !

  • FungalDx26 invites abstract submissions across key areas of fungal disease diagnostics. Priority for presentation at the main conference will be given to clinical case submissions that highlight diagnostic challenges and illustrate a bench-to-bedside approach.
  • Abstracts can be submitted via the online portal below. Accepted cases will be presented by the submitter during the conference in an interactive session, alongside a panel of expert discussants.
  • ISHAM Membership is not required to submit an abstract. However, if you apply for any funding from ISHAM (i.e. Travel Award), Membership is REQUIRED to receive an award. 
  • The abstract submitter must be the first/presenting author.
  • The presenting author must register for the event using the same email address used for the abstract submission.
  • The Presenting Author agrees to be available to present in Bethesda, MD, USA on December 2-4, 2026.
  • The Presenting Author is responsible for all expenses related to the presentation of their abstract(s) if accepted to the program.
  • Fungal Dx 2026 does not provide funding, registration waivers or other support.
  • Fungal Dx 2026 must be the first major presentation of the abstract.
  • Encore Abstracts presented at previous meetings will not be accepted.

Important Dates:

Early Abstracts:

  • Abstract Submission Open: Jan 10, 2026
  • Abstract Submission Close: April 15, 2026 (12:00 PM US EST)
  • Abstract Decision Notifications Sent: May 25, 2026

Regular Abstracts

  • Abstract Submission Open: March 16, 2026
  • Abstract Submission Close: July 7, 2026 (2:00 PM ET)
  • Abstract Decision Notifications Sent: Aug 4, 2026



Submission deadlines are firm.

Late abstracts will not be accepted.

Submit Abstract

SPECIAL NOTE:

  • Any communication about your abstract will come from isham@fungaldx.com.
  • Please add isham@fungaldx.com,and secretary@fungaldx.com 
  • your "Safe Senders" list in your email program to alleviate bounce backs or your notifications being sent to a junk folder.
  • Registration waivers are not available.
  • The Presenting Author must be registered by September 1, 2026 or the abstract will be withdrawn.
  • Remote presentations are not available.

Key Focus Areas :

  1. Epidemiology and Global Burden of Fungal Diseases  
  2. Superficial and Cutaneous Mycoses: Clinical Spectrum and Diagnostics
  3.  Aspergillus Diseases: Clinical, Laboratory, and Radiologic Perspectives
  4. Cryptococcosis, Mucormycosis, and Rare Mold Infections
  5. Candida and Candidiasis: Diagnostic Strategies, Emerging Challenges, and Surveillance
  6. Fungal immunodiagnostics, Antifungal Therapies, Antifungal Resistance
  7. Therapeutic Drug Monitoring, Antifungal Stewardship, and WHO Diagnostic Frameworks
  8. Diagnostic Stewardship, Guidelines, and Resource-Limited Approaches
  9. Advanced Diagnostics: Histopathology, Molecular Testing, and Artificial Intelligence
  10. Fungal Surveillance, Outbreak Investigations, and Environmental Health
  11. Endemic Dimorphs and Detection of Pneumocystis jirovecii
  12. Zoonotic Fungi and Veterinary Mycoses: Diagnosis, Emerging Threats, and One Health Implications

Abstract Submission: Step-by-Step Guide

General terms

To begin the submission process, you must first create a contact using this link or the submission buttons on this page. After creating a contact, additional tabs will appear that will enable you to upload and submit your presentation.

  • ISHAM Membership is not required to submit an abstract. However, if you apply for any funding from ISHAM (i.e. Travel Award), membership is REQUIRED to receive an award. 
  • The abstract submitter must be the first/presenting author.
  • The Presenting Author must be registered by September 1, 2026 or the abstract will be withdrawn.
  • Registration waivers are not available.
  • The presenting author must register for the event using the same email address used for the abstract submission.
  • The Presenting Author agrees to be available to present in Bethesda, MD, USA on December 2-4, 2026.
  • Remote presentations are not available.
  • The Presenting Author is responsible for all expenses related to the presentation of their abstract(s) if accepted to the program.
  • Fungal Dx 2026 does not provide funding, registration waivers or other support.
  • Fungal Dx 2026 must be the first major presentation of the abstract.
  • Abstracts presented at previous meetings will not be accepted.

Theme

  • Antifungal resistance
  • Artificial intelligence/Machine learning
  • Biomarkers
  • MALDI-TOF
  •  Microscopy and Histopathology
  • Molecular Diagnostics
  • Next generation Sequencing &Metagenomics
  • ·Point-of-care diagnostics      
  • Serological Assays
  • Others

Presentation Type

Abstracts are presented in Oral or Poster format at Fungal Dx 26 Conference.

  • Oral abstracts are presented within scientific sessions.
  • Posters are presented in the Poster Hall with abstracts printed and displayed on a poster board.

Abstract Formatting

  • Your abstract may have up to 400 words (minimum 100 words), which does not include title, authors, groups and affiliations.
  • Your abstract should be written with the use of the following bolded headers:
  • Background
  • Methods
  • Results
  • Conclusion
  • Spaces are not counted.
  • Do not include abstract title, authors or keywords in abstract text.
  • Tables and graphics (maximum of 500 characters) are not included in the character count.